352 related articles for article (PubMed ID: 28975891)
21. Preferential usage of T-cell receptor alpha beta variable regions among tumor-infiltrating lymphocytes in primary human malignant melanomas.
Thor Straten P; Schøller J; Hou-Jensen K; Zeuthen J
Int J Cancer; 1994 Jan; 56(1):78-86. PubMed ID: 8262682
[TBL] [Abstract][Full Text] [Related]
22. CCL17 and CCL22 chemokines within tumor microenvironment are related to accumulation of Foxp3+ regulatory T cells in gastric cancer.
Mizukami Y; Kono K; Kawaguchi Y; Akaike H; Kamimura K; Sugai H; Fujii H
Int J Cancer; 2008 May; 122(10):2286-93. PubMed ID: 18224687
[TBL] [Abstract][Full Text] [Related]
23. Fibroblast activation protein-targeted near-infrared photoimmunotherapy depletes immunosuppressive cancer-associated fibroblasts and remodels local tumor immunity.
Akai M; Noma K; Kato T; Nishimura S; Matsumoto H; Kawasaki K; Kunitomo T; Kobayashi T; Nishiwaki N; Kashima H; Kikuchi S; Ohara T; Tazawa H; Choyke PL; Kobayashi H; Fujiwara T
Br J Cancer; 2024 Jun; 130(10):1647-1658. PubMed ID: 38555315
[TBL] [Abstract][Full Text] [Related]
24. Fibroblast Heterogeneity and Immunosuppressive Environment in Human Breast Cancer.
Costa A; Kieffer Y; Scholer-Dahirel A; Pelon F; Bourachot B; Cardon M; Sirven P; Magagna I; Fuhrmann L; Bernard C; Bonneau C; Kondratova M; Kuperstein I; Zinovyev A; Givel AM; Parrini MC; Soumelis V; Vincent-Salomon A; Mechta-Grigoriou F
Cancer Cell; 2018 Mar; 33(3):463-479.e10. PubMed ID: 29455927
[TBL] [Abstract][Full Text] [Related]
25. Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives.
Mao X; Xu J; Wang W; Liang C; Hua J; Liu J; Zhang B; Meng Q; Yu X; Shi S
Mol Cancer; 2021 Oct; 20(1):131. PubMed ID: 34635121
[TBL] [Abstract][Full Text] [Related]
26. Frequency, suppressive capacity, recruitment and induction mechanisms of regulatory T cells in sinonasal squamous cell carcinoma and nasal inverted papilloma.
Lou H; Fang J; Li P; Zhou W; Wang Y; Fan E; Li Y; Wang H; Liu Z; Xiao L; Wang C; Zhang L
PLoS One; 2015; 10(5):e0126463. PubMed ID: 26020249
[TBL] [Abstract][Full Text] [Related]
27. Tumor-Infiltrating T Cells in Skin Basal Cell Carcinomas and Squamous Cell Carcinomas: Global Th1 Preponderance with Th17 Enrichment-A Cross-Sectional Study.
Cunha D; Neves M; Silva D; Silvestre AR; Nunes PB; Arrobas F; Ribot JC; Ferreira F; Moita LF; Soares-de-Almeida L; Silva JM; Filipe P; Ferreira J
Cells; 2024 Jun; 13(11):. PubMed ID: 38891095
[TBL] [Abstract][Full Text] [Related]
28. Link between tumor-promoting fibrous microenvironment and an immunosuppressive microenvironment in stage I lung adenocarcinoma.
Sakai T; Aokage K; Neri S; Nakamura H; Nomura S; Tane K; Miyoshi T; Sugano M; Kojima M; Fujii S; Kuwata T; Ochiai A; Iyoda A; Tsuboi M; Ishii G
Lung Cancer; 2018 Dec; 126():64-71. PubMed ID: 30527194
[TBL] [Abstract][Full Text] [Related]
29. Cancer-Associated Fibroblasts in Mycosis Fungoides Promote Tumor Cell Migration and Drug Resistance through CXCL12/CXCR4.
Aronovich A; Moyal L; Gorovitz B; Amitay-Laish I; Naveh HP; Forer Y; Maron L; Knaneh J; Ad-El D; Yaacobi D; Barel E; Erez N; Hodak E
J Invest Dermatol; 2021 Mar; 141(3):619-627.e2. PubMed ID: 32795528
[TBL] [Abstract][Full Text] [Related]
30. Expansion and de novo generation of potentially therapeutic regulatory T cells in patients with autoimmune hepatitis.
Longhi MS; Meda F; Wang P; Samyn M; Mieli-Vergani G; Vergani D; Ma Y
Hepatology; 2008 Feb; 47(2):581-91. PubMed ID: 18220288
[TBL] [Abstract][Full Text] [Related]
31. In vivo characterization of the inflammatory infiltrate and apoptotic status in imiquimod-treated basal cell carcinoma.
De Giorgi V; Salvini C; Chiarugi A; Paglierani M; Maio V; Nicoletti P; Santucci M; Carli P; Massi D
Int J Dermatol; 2009 Mar; 48(3):312-21. PubMed ID: 19261026
[TBL] [Abstract][Full Text] [Related]
32. Peritumoral Clefting and Expression of MMP-2 and MMP-9 in Basal Cell Carcinoma of the Skin.
Manola I; Mataic A; Drvar DL; Pezelj I; Dzombeta TR; Kruslin B
In Vivo; 2020; 34(3):1271-1275. PubMed ID: 32354918
[TBL] [Abstract][Full Text] [Related]
33. Stromal PD-L1-Positive Regulatory T cells and PD-1-Positive CD8-Positive T cells Define the Response of Different Subsets of Non-Small Cell Lung Cancer to PD-1/PD-L1 Blockade Immunotherapy.
Wu SP; Liao RQ; Tu HY; Wang WJ; Dong ZY; Huang SM; Guo WB; Gou LY; Sun HW; Zhang Q; Xie Z; Yan LX; Su J; Yang JJ; Zhong WZ; Zhang XC; Wu YL
J Thorac Oncol; 2018 Apr; 13(4):521-532. PubMed ID: 29269008
[TBL] [Abstract][Full Text] [Related]
34. Genetic and functional interaction network analysis reveals global enrichment of regulatory T cell genes influencing basal cell carcinoma susceptibility.
Adolphe C; Xue A; Fard AT; Genovesi LA; Yang J; Wainwright BJ
Genome Med; 2021 Feb; 13(1):19. PubMed ID: 33549134
[TBL] [Abstract][Full Text] [Related]
35. Increased populations of regulatory T cells in peripheral blood and tumor-infiltrating lymphocytes in patients with gastric and esophageal cancers.
Ichihara F; Kono K; Takahashi A; Kawaida H; Sugai H; Fujii H
Clin Cancer Res; 2003 Oct; 9(12):4404-8. PubMed ID: 14555512
[TBL] [Abstract][Full Text] [Related]
36. Interleukin-17 and interleukin-22 promote tumor progression in human nonmelanoma skin cancer.
Nardinocchi L; Sonego G; Passarelli F; Avitabile S; Scarponi C; Failla CM; Simoni S; Albanesi C; Cavani A
Eur J Immunol; 2015 Mar; 45(3):922-31. PubMed ID: 25487261
[TBL] [Abstract][Full Text] [Related]
37. Expansion of Tumor-reactive T Cells From Patients With Pancreatic Cancer.
Meng Q; Liu Z; Rangelova E; Poiret T; Ambati A; Rane L; Xie S; Verbeke C; Dodoo E; Del Chiaro M; Löhr M; Segersvärd R; Maeurer MJ
J Immunother; 2016; 39(2):81-9. PubMed ID: 26849077
[TBL] [Abstract][Full Text] [Related]
38. Correlation between infiltration of FOXP3+ regulatory T cells and expression of B7-H1 in the tumor tissues of gastric cancer.
Hou J; Yu Z; Xiang R; Li C; Wang L; Chen S; Li Q; Chen M; Wang L
Exp Mol Pathol; 2014 Jun; 96(3):284-91. PubMed ID: 24657498
[TBL] [Abstract][Full Text] [Related]
39. The microenvironment in primary cutaneous melanoma with associated spontaneous tumor regression: evaluation for T-regulatory cells and the presence of an immunosuppressive microenvironment.
Gray A; Grushchak S; Mudaliar K; Kliethermes S; Carey K; Hutchens KA
Melanoma Res; 2017 Apr; 27(2):104-109. PubMed ID: 28125447
[TBL] [Abstract][Full Text] [Related]
40. Crosstalk between Tumor-Infiltrating Immune Cells and Cancer-Associated Fibroblasts in Tumor Growth and Immunosuppression of Breast Cancer.
Soongsathitanon J; Jamjuntra P; Sumransub N; Yangngam S; De la Fuente M; Landskron G; Thuwajit P; Hermoso MA; Thuwajit C
J Immunol Res; 2021; 2021():8840066. PubMed ID: 34337083
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]